Reversing Age-Associated Inflammation

Leading life sciences venture capital firms Canaan Partners and Domain Ventures visited Brown with Dr. John Sedivy and IECV team members in October. Next up: IECV will facilitate a scientific and commercial exploration to license and fund a company based upon Dr. Sedivy’s patent-pending intellectual property for compositions and methods for preventing and reversing age-associated inflammation.